Table 3.
Controlled ovarian hyperstimulation regimens.
| Study | Type of protocol | Dual trigger group | hCG group |
|---|---|---|---|
| Schachter et al., 2008 | Antagonist | hMG + Cetrorelix | HMG + Cetrorelix |
| Kim et al., 2014 | Antagonist | 150-225 UI rFSH + Cetrorelix | 150-225 UI rFSH + Cetrorelix |
| Decleer et al., 2014 | Antagonist | 200 UI rFSH + Ganirelix | 200 UI rFSH + Ganirelix |
| Mahajan et al., 2016 | Antagonist | FSH + hMH-HP + Cetrorelix | FSH + hMH-HP + Cetrorelix |
| Maged et al., 2021 | Antagonist | 300 UI r-FSH + 150 UI LH+FSH + Cetrorelix | 300 UI r-FSH + 150 UI LH+FSH + Cetrorelix |
| Haas et al., 2020 | Antagonist | 150-225 UI r-FSH + Ganirelix | 150-225 UI r-FSH + Ganirelix |